Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On circulationmedicines "the decision was taken to abolish the state registration and exclusion from the state register of medicinal products for medical use of the medicinal product (registration certificate No. N013764 / 01 of 28.02.2008 issued by Eli Lilly East SA, Switzerland):
Ziprex® (trade name of the medicinal product)
Olanzapine (international non-proprietary or grouping or chemical name)
lyophilizate for the preparation of a solution for intramuscular administration, 10 mg (dosage form, dosage)
Lilly Pharma Fertigung und Distribution GmbH & Co. KG, Germany Teichweg 3, 35396 Giessen, Germany (name and address of the location of the manufacturer of the medicinal product)
on the basis of a filing by an authorized legal entity of the IP JSC "Eli Lilly East SA" applications for the abolition of state registration of a medicinal product.